These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3073650)

  • 21. Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancer.
    Hageboutros A; Rogatko A; Newman EM; McAleer C; Brennan J; LaCreta FP; Hudes GR; Ozols RF; O'Dwyer PJ
    Cancer Chemother Pharmacol; 1995; 35(3):205-12. PubMed ID: 7805178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
    Davis ST; Berger SH
    Mol Pharmacol; 1989 Apr; 35(4):422-7. PubMed ID: 2523018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of the number of FdUMP binding sites of thymidylate synthase and folate pools in human colorectal carcinomas following the administration of tegafur and uracil: preliminary report].
    Omura K; Kawakami K; Ishida F; Hashimoto T; Matsu T; Adachi I; Watanabe Y
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):193. PubMed ID: 8464418
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
    van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
    Davis ST; Berger SH
    Mol Pharmacol; 1993 May; 43(5):702-8. PubMed ID: 8502227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
    Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formyltetrahydrofolate hydrolase, a regulatory enzyme that functions to balance pools of tetrahydrofolate and one-carbon tetrahydrofolate adducts in Escherichia coli.
    Nagy PL; Marolewski A; Benkovic SJ; Zalkin H
    J Bacteriol; 1995 Mar; 177(5):1292-8. PubMed ID: 7868604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Estimation of level of enzyme induction of thymidine phosphorylase, dihydropyrimidine dehydrogenase, and thymidylate synthase in primary and recurrent breast cancer].
    Morimoto K; Koh M
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):529-38. PubMed ID: 15114696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy.
    Bertino JR; Mini E; Fernandes DJ
    Semin Oncol; 1983 Jun; 10(2 Suppl 2):2-5. PubMed ID: 6867754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
    Peters GJ; Backus HH; Freemantle S; van Triest B; Codacci-Pisanelli G; van der Wilt CL; Smid K; Lunec J; Calvert AH; Marsh S; McLeod HL; Bloemena E; Meijer S; Jansen G; van Groeningen CJ; Pinedo HM
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):194-205. PubMed ID: 12084461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ternary complex formation with 5-fluoro-2'-deoxyuridylate and the kinetic properties of thymidylate synthase from Lactobacillus leichmannii.
    Rao KN
    Indian J Biochem Biophys; 1993 Apr; 30(2):103-10. PubMed ID: 8354517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic analysis of (6S)-5-formyltetrahydrofolate (1-CF), (6R)-5-formyltetrahydrofolate (d-CF) and 5-methyltetrahydrofolate (5-CH3-THF) in patients receiving constant i.v. infusion of high-dose (6R,S)-5-formyltetrahydrofolate (leucovorin).
    Straw JA; Newman EM
    Adv Exp Med Biol; 1988; 244():53-8. PubMed ID: 3266829
    [No Abstract]   [Full Text] [Related]  

  • 33. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.
    Scanlon KJ; Newman EM; Lu Y; Priest DG
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8923-5. PubMed ID: 3466165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thymidylate synthase gene promoter polymorphism in patients with advanced head and neck cancer treated by radio- and 5-fluorouracil chemotherapy].
    Kiss-László Z; Nagy B; Thurzó L; Szabó J
    Magy Onkol; 2006; 50(1):33-7. PubMed ID: 16617381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.
    Shirota Y; Stoehlmacher J; Brabender J; Xiong YP; Uetake H; Danenberg KD; Groshen S; Tsao-Wei DD; Danenberg PV; Lenz HJ
    J Clin Oncol; 2001 Dec; 19(23):4298-304. PubMed ID: 11731512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
    Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
    Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells.
    Antosiewicz A; Jarmuła A; Przybylska D; Mosieniak G; Szczepanowska J; Kowalkowska A; Rode W; Cieśla J
    J Biomol Struct Dyn; 2017 May; 35(7):1474-1490. PubMed ID: 27187663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic studies on drug-resistant variants of Escherichia coli thymidylate synthase: functional effects of amino acid substitutions at residue 4.
    Mahdavian E; Spencer HT; Dunlap RB
    Arch Biochem Biophys; 1999 Aug; 368(2):257-64. PubMed ID: 10441376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of strain in a stereospecific catalytic mechanism: crystal structures of Escherichia coli thymidylate synthase bound to FdUMP and methylenetetrahydrofolate.
    Hyatt DC; Maley F; Montfort WR
    Biochemistry; 1997 Apr; 36(15):4585-94. PubMed ID: 9109668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats.
    Yoshisue K; Hironaga K; Yamaguchi S; Yamamoto A; Nagayama S; Kawaguchi Y
    Cancer Chemother Pharmacol; 2000; 46(1):51-6. PubMed ID: 10912578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.